Trial
NCT04808115
IIT PH1 KDS-1001 in Patients With CML
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
Kiadis Pharma
Condition
CML (Chronic Myelogenous Leukemia
Intervention
KDS-1001
Why stopped
Study halted prematurely, prior to enrollment of first participant.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-26